2 completed, 1 not yet recruiting. 2 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 1, Not yet recruiting 1 |
| Phase 2 | 1 | Completed 1 |
Follow Abacavir (ABC): new trials by email Literature Review of Abacavir (ABC) trials Research Report on Abacavir (ABC)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| An Adaptive Platform Trial for Evaluation of Novel Treatment Regimens in Children and Adolescents With HIV in Africa Dolutegravir (DTG), Abacavir (ABC), Lamivudine (3TC) - HIV Infection | Phase 3 | Not yet recruiting | University College, London | 800 | 2026-11-01 | 2026-08-28 |
| Inhibition of Reverse Transcription in Aicardi-Goutières Syndrome Abacavir (ABC), Lamivudine (3TC), Abacavir (ABC)+Lamivudine (3TC)+Zidovudine (AZT) - Aicardi-Goutières Syndrome | Phase 2 | Completed | University of Edinburgh | 13 | 2022-08-24 | 2024-05-09 |
| Treatment Options for Protease Inhibitor-exposed Children Efavirenz (EFV), Lopinavir/ritonavir (LPV/r), Stavudine (D4T) - HIV/AIDS, HIV Infections | Phase 3 | Completed | Columbia University | 300 | 2010-07-01 | 2017-03-13 |
HIV Infections (2) · Acquired Immunodeficiency Syndrome (1)
Columbia University (1) · University College, London (1) · University of Edinburgh (1)
South Africa (1) · United Kingdom (1)
Louise Kuhn, PhD (1) · Yanick Crow (1)
R01HD061255 (1)